Abstract
Adriamycin (ADR) accumulates in well-perfused organs in the rat. This effect is especially evident for long periods in marrow and spleen of healthy animals. In rats bearing the Brown Norway Acute Myeloid Leukaemia (BNML) the in vivo distribution is significantly different. Maximum ADR levels in those organs which are morphologically infiltrated by leukaemic cells are significantly lower than in normal rats, while the persistence of measurable ADR concentrations does not change. On the contrary, ADR concentrations in organs not infiltrated by leukaemic cells are the same or slightly higher than in normal rats. Possible causes for these differences are either the differential properties of normal and leukaemic cells in their uptake and excretion of ADR, or anatomical and vascular changes. It is evident that, significantly different from normal. This observation may help in the prevention of toxicity by drug monitoring in serum.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Rights and permissions
About this article
Cite this article
Sonneveld, P., Van Bekkum, D. Different distribution of adriamycin in normal and leukaemic rats. Br J Cancer 43, 464–470 (1981). https://doi.org/10.1038/bjc.1981.68
Issue Date:
DOI: https://doi.org/10.1038/bjc.1981.68
This article is cited by
-
Animal models of acute myelogenous leukaemia – development, application and future perspectives
Leukemia (2005)
-
Anthracycline antitumour agents
Pharmaceutisch Weekblad Scientific Edition (1986)